{"id":44858,"date":"2021-03-03T18:42:52","date_gmt":"2021-03-03T09:42:52","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=44858"},"modified":"2021-03-09T20:07:04","modified_gmt":"2021-03-09T11:07:04","slug":"impel-neuropharma-partners-with-veeva-systems-to-build-integrated-digital-first-commercial-foundation","status":"publish","type":"post","link":"https:\/\/pantheon.veeva.com\/jp\/news\/impel-neuropharma-partners-with-veeva-systems-to-build-integrated-digital-first-commercial-foundation\/","title":{"rendered":"Impel NeuroPharma\u793e\u304cVeeva Systems\u3068\u63d0\u643a\u3002\u30c7\u30b8\u30bf\u30eb\u30d5\u30a1\u30fc\u30b9\u30c8\u3092\u8ffd\u6c42\u3057\u3001\u7d71\u5408\u5316\u3055\u308c\u305f\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u57fa\u76e4\u3092\u69cb\u7bc9"},"content":{"rendered":"<p style=\"text-align: center;\">\uff5e Impel\u793e\u306fVeeva\u306e\u30bd\u30d5\u30c8\u30a6\u30a8\u30a2\u3001\u30c7\u30fc\u30bf\u3001\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u3092\u63a1\u7528\u3057\u3001<\/p>\n<p style=\"text-align: center;\">\u4e0a\u5e02\u524d\u8a08\u753b\u3068\u30c7\u30b8\u30bf\u30eb\u30d5\u30a1\u30fc\u30b9\u30c8\u3067\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u6d3b\u52d5\u306e\u5b9f\u65bd\u3092\u52a0\u901f \uff5e<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\">2021\u5e743\u67083\u65e5<\/p>\n<p style=\"text-align: right;\">Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p><strong><a href=\"https:\/\/impelnp.com\/\">Impel NeuroPharma<\/a><\/strong>\u793e\uff08\u4ee5\u4e0b Impel\u793e\uff09\u3068Veeva Systems\u3010NYSE:VEEV\u3011\uff08\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b Veeva\uff09\u306f\u3001Impel\u793e\u304c\u4e2d\u67a2\u795e\u7d4c\u7cfb\uff08CNS\uff09\u75be\u60a3\u306b\u304a\u3051\u308b\u9ad8\u3044\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u306b\u5bfe\u51e6\u3059\u308b\u3079\u304f\u3001\u9769\u65b0\u7684\u306a\u533b\u85ac\u54c1\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u62e1\u5145\u3059\u308b\u4e2d\u3001\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u7de0\u7d50\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u4e21\u793e\u306fImpel\u793e\u306e\u7247\u982d\u75db\u6cbb\u7642\u85acINP104\u306e\u91cd\u8981\u306a\u4e0a\u5e02\u524d\u306e\u6e96\u5099\u306b\u304a\u3044\u3066\u9023\u643a\u3057\u307e\u3059\u3002\u3053\u306e\u6cbb\u7642\u85ac\u306f\u3001\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u306e\u627f\u8a8d\u3092\u5f97\u3089\u308c\u308c\u3070\u3001TRUDHESA&#x2122;\u306e\u88fd\u54c1\u540d\u3067\u8ca9\u58f2\u3055\u308c\u308b\u4e88\u5b9a\u3067\u3059\u3002Impel\u793e\u306f<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/commercial-cloud\/\">Veeva Commercial Cloud<\/a><\/strong>\u306e\u5c0e\u5165\u3067\u3001\u30c7\u30fc\u30bf\u3001\u30bd\u30d5\u30c8\u30a6\u30a8\u30a2\u3001\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u30b5\u30fc\u30d3\u30b9\u3092\u7db2\u7f85\u3059\u308b\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30b9\u30a4\u30fc\u30c8\u306e\u3059\u3079\u3066\u3092\u5229\u7528\u3057\u3001\u6226\u7565\u7684\u306b\u73fe\u5834\u306e\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u52a0\u901f\u3055\u305b\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f<strong><a href=\"https:\/\/www.veeva.com\/resources\/impel-neuropharma-partners-with-veeva-systems-to-build-integrated-digital-first-commercial-foundation\/\">\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n<p>&nbsp;<\/p>\n<p>Impel\u793e\u306e\u30c1\u30a7\u30a2\u30de\u30f3\u517cCEO\u3067\u3042\u308bAdrian Adams\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c1\u6708\u306bFDA\u304c\u5f53\u793e\u306eTRUDHESA&#x2122;\u306e\u65b0\u85ac\u627f\u8a8d\u7533\u8acb\uff08NDA\uff09\u3092\u53d7\u7406\u3057\u3001\u5be9\u67fb\u306b\u5165\u3063\u305f\u3053\u3068\u3092\u559c\u3070\u3057\u304f\u601d\u3063\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u91cd\u8981\u306a\u7bc0\u76ee\u306f\u3001\u5f53\u793e\u304cVeeva\u3068\u306e\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u958b\u59cb\u3059\u308b\u7d76\u597d\u306e\u6a5f\u4f1a\u3068\u6349\u3048\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u5b9f\u7e3e\u3042\u308b\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306e\u30ea\u30fc\u30c0\u30fc\u3067\u3042\u308a\u3001\u5f53\u793e\u306e\u53b3\u3057\u3044\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u306b\u5bfe\u5fdc\u3067\u304d\u308b\u7406\u60f3\u7684\u306a\u63d0\u643a\u5148\u3067\u3059\u3002Veeva\u306e\u652f\u63f4\u3068\u5c02\u9580\u77e5\u8b58\u306b\u3088\u308a\u3001\u52b9\u7387\u7684\u3067\u30c7\u30b8\u30bf\u30eb\u30d5\u30a1\u30fc\u30b9\u30c8\u304b\u3064\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u78ba\u4fdd\u3057\u305f\u30a2\u30d7\u30ed\u30fc\u30c1\u304c\u3001\u5f53\u793e\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30ea\u30bc\u30fc\u30b7\u30e7\u30f3\u6848\u4ef6\u3092\u78ba\u5b9f\u306b\u5b9f\u65bd\u3067\u304d\u308b\u3067\u3057\u3087\u3046\u3002\u305d\u3057\u3066\u672c\u5e74\u5f8c\u534a\u306b\u306f\u3001FDA\u306e\u627f\u8a8d\u304c\u5f97\u3089\u308c\u308b\u3053\u3068\u3092\u671f\u5f85\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n<p>FDA\u306b\u3088\u308bImpel\u793e\u306eTRUDHESA&#x2122;\u306eNDA\u5be9\u67fb\u306f\u3001\u3053\u306e\u65ac\u65b0\u306a\u6cbb\u7642\u85ac\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30ea\u30bc\u30fc\u30b7\u30e7\u30f3\u306b\u5411\u3051\u305f\u5927\u304d\u306a\u524d\u9032\u3092\u610f\u5473\u3057\u307e\u3059\u3002TRUDHESA&#x2122;\u306fImpel\u793e\u304c\u72ec\u81ea\u306b\u958b\u767a\u3057\u305f\u3001\u4eca\u307e\u3067\u306b\u985e\u3092\u898b\u306a\u3044\u30d7\u30ec\u30b7\u30b8\u30e7\u30f3\u30fb\u30aa\u30eb\u30d5\u30a1\u30af\u30c8\u30ea\u30fc\u30fb\u30c7\u30ea\u30d0\u30ea\u30fc\uff08Precision Olfactory Delivery<sup>\u00ae<\/sup>: POD\uff09\u6280\u8853\u3092\u4f7f\u7528\u3057\u3001\u8840\u7ba1\u304c\u5bc6\u96c6\u3059\u308b\u9f3b\u8154\u4e0a\u90e8\u306b\u76f4\u63a5\u3001\u6cbb\u7642\u85ac\u3092\u9001\u9054\u3059\u308b\u6700\u521d\u3067\u552f\u4e00\u306e\u88fd\u54c1\u3067\u3059\u3002\u30dd\u30f3\u30d7\u3084\u30b9\u30d7\u30ec\u30fc\u306a\u3069\u5f93\u6765\u306e\u7d4c\u9f3b\u9001\u9054\u30b7\u30b9\u30c6\u30e0\u306f\u3001\u9f3b\u8154\u4e0b\u90e8\u306b\u85ac\u5264\u3092\u9001\u9054\u3059\u308b\u305f\u3081\u3001\u9001\u9054\u304c\u4e88\u6e2c\u4e0d\u53ef\u80fd\u3067\u8840\u6d41\u3078\u306e\u5438\u53ce\u304c\u53ef\u5909\u7684\u3067\u3001\u6709\u52b9\u6027\u306b\u3070\u3089\u3064\u304d\u304c\u751f\u3058\u308b\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u8907\u6570\u306e\u7814\u7a76\u3067\u3001Impel\u793e\u306ePOD<sup>\u00ae<\/sup>\u6280\u8853\u306f\u9001\u9054\u3092\u3088\u308a\u5b89\u5b9a\u3055\u305b\u3001\u8840\u6d41\u4e2d\u3078\u306e\u5438\u53ce\u304c\u901f\u3084\u304b\u306b\u306a\u308b\u305f\u3081\u3001\u53cd\u5fdc\u304c\u3088\u308a\u4e88\u6e2c\u53ef\u80fd\u3068\u306a\u308b\u4e00\u65b9\u3001\u60a3\u8005\u306b\u3068\u3063\u3066\u4f7f\u3044\u3084\u3059\u3044\u3053\u3068\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u65b0\u3057\u3044\u9001\u9054\u6280\u8853\u306f\u3001\u767a\u4f5c\u4e2d\u306b\u60aa\u5fc3\u3084\u5614\u5410\u3092\u7d4c\u9a13\u3059\u308b\u5927\u591a\u6570\u306e\u7247\u982d\u75db\u60a3\u8005\u306b\u3068\u3063\u3066\u3001\u3068\u308a\u308f\u3051\u610f\u7fa9\u304c\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u4e0a\u5e02\u6e96\u5099\u3092\u52a0\u901f\u3055\u305b\u308b\u305f\u3081\u3001Impel\u793e\u306fVeeva\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3092\u5c0e\u5165\u3057\u307e\u3059\u3002\u305f\u3068\u3048\u3070\u30de\u30eb\u30c1\u30c1\u30e3\u30cd\u30eb<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/multichannel-crm\/\">Veeva CRM<\/a><\/strong>\u306f\u3001\u533b\u5e2b\u3068\u5bfe\u9762\u3084\u30c7\u30b8\u30bf\u30eb\u3067\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u69cb\u7bc9\u3059\u308b\u57fa\u76e4\u3067\u3042\u308a\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/news\/veeva-data-cloud-to-deliver-new-approach-for-patient-and-prescriber-data\/\">Veeva Data Cloud<\/a><\/strong>\u306f\u7e26\u65ad\u7684\u306a\u60a3\u8005\u30c7\u30fc\u30bf\u304b\u3089\u9069\u5207\u306a\u60a3\u8005\u30b0\u30eb\u30fc\u30d7\u3092\u52b9\u7387\u7684\u306b\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3057\u307e\u3059\u3002\u307e\u305f\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/services\/\">Veeva\u30d3\u30b8\u30cd\u30b9\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u30b5\u30fc\u30d3\u30b9<\/a><\/strong>\u306f\u9867\u5ba2\u4e2d\u5fc3\u306e\u6226\u7565\u306e\u7b56\u5b9a\u30fb\u5b9f\u65bd\u3092\u652f\u63f4\u3057\u3001Impel\u793e\u306e\u55b6\u696d\u62c5\u5f53\u8005\u306f\u533b\u7642\u5f93\u4e8b\u8005\u3068\u306e\u30bf\u30fc\u30b2\u30c3\u30c8\u3092\u7d5e\u3063\u305f\u3084\u308a\u3068\u308a\u306e\u4fa1\u5024\u3092\u9ad8\u3081\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>Veeva\u306e\u5275\u696d\u8005\u517cCEO\u3067\u3042\u308bPeter Gassner\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cImpel\u793e\u306fCNS\u306a\u3069\u306e\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u306e\u9ad8\u3044\u75be\u60a3\u306b\u5bfe\u3057\u3066\u4eca\u307e\u3067\u306b\u306a\u3044\u6cbb\u7642\u30a2\u30d7\u30ed\u30fc\u30c1\u3092\u958b\u62d3\u3057\u3066\u304a\u308a\u3001Veeva\u306f\u305d\u308c\u3089\u9769\u65b0\u7684\u306a\u88fd\u54c1\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30ea\u30bc\u30fc\u30b7\u30e7\u30f3\u3092\u652f\u63f4\u3067\u304d\u308b\u3053\u3068\u3092\u8a87\u308a\u306b\u601d\u3044\u307e\u3059\u3002\u5f53\u793e\u306f\u3001\u696d\u754c\u306e\u30c7\u30b8\u30bf\u30eb\u5316\u3078\u306e\u79fb\u884c\u3092\u52a0\u901f\u3057\u3001\u60a3\u8005\u69d8\u306b\u65b0\u85ac\u3092\u8fc5\u901f\u306b\u304a\u5c4a\u3051\u3059\u308b\u305f\u3081\u306e\u6700\u5148\u7aef\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u30c7\u30fc\u30bf\u3001\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u306b\u30b3\u30df\u30c3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010<\/strong><strong>TRUDHESA&#x2122;<\/strong><strong>\u306b\u3064\u3044\u3066\u3011<\/strong><strong><br \/>\n<\/strong>Impel NeuroPharma\u793e\u306f\u3001\u7247\u982d\u75db\u306e\u6025\u6027\u671f\u6cbb\u7642\u306e\u305f\u3081\u306e\u9769\u65b0\u7684\u306a\u65b0\u898f\u6cbb\u7642\u6cd5\u3068\u3057\u3066\u3001TRUDHESA&#x2122;\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002TRUDHESA&#x2122;\u306f\u30b8\u30d2\u30c9\u30ed\u30a8\u30eb\u30b4\u30bf\u30df\u30f3\u30e1\u30b7\u30eb\u9178\u5869\uff08DHE\uff09\u3092\u6700\u9069\u5316\u3057\u3001\u7247\u982d\u75db\u306e\u767a\u4f5c\u4e2d\u3001\u6ce8\u5c04\u3092\u3059\u308b\u3053\u3068\u306a\u304f\u3001\u3069\u306e\u30bf\u30a4\u30df\u30f3\u30b0\u3067\u6295\u4e0e\u3057\u3066\u3082\u5373\u52b9\u6027\u3068\u6301\u7d9a\u6027\u3092\u6301\u3064\u3001\u7247\u982d\u75db\u306e\u5168\u9762\u7684\u306a\u7de9\u548c\u306e\u9054\u6210\u3092\u3081\u3056\u3057\u3066\u3044\u307e\u3059\u3002\u91cd\u8981\u306a\u70b9\u306f\u3001TRUDHESA&#x2122;\u306f\u4ed6\u306e\u7d4c\u9f3b\u6295\u4e0e\u306eFDA\u627f\u8a8d\u85ac\u304a\u3088\u3073\u6cbb\u9a13\u85ac\u3068\u6bd4\u8f03\u3057\u3066\u3001\u4f4e\u7528\u91cf\u306eDHE\u3092\u9001\u9054\u3059\u308b\u3088\u3046\u8a2d\u8a08\u3055\u308c\u3066\u3044\u308b\u3053\u3068\u3067\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u60a3\u8005\u306f\u9f3b\u8154\u4e0b\u90e8\u3078\u306e\u9001\u9054\u3067\u751f\u3058\u308b\u3053\u3068\u306e\u3042\u308b\u4e0d\u5feb\u306a\u526f\u4f5c\u7528\u3092\u7d4c\u9a13\u3059\u308b\u3053\u3068\u306a\u304f\u3001\u78ba\u7acb\u3055\u308c\u305fDHE\u306e\u6709\u52b9\u6027\u306e\u6069\u6075\u3092\u53d7\u3051\u3089\u308c\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>TRUDHESA&#x2122;\u306f\u3001Impel\u793e\u306e\u5674\u9727\u5264\u5411\u3051\u306ePOD\u6280\u8853\u306b\u3088\u308a\u3001\u8840\u7ba1\u304c\u5bc6\u96c6\u3057\u3066\u3044\u3066\u52b9\u7387\u7684\u306a\u85ac\u7269\u306e\u6295\u4e0e\u90e8\u4f4d\u3068\u3057\u3066\u7406\u60f3\u7684\u3067\u3042\u308b\u9f3b\u8154\u4e0a\u90e8\u306b\u3001DHE\u306e\u6700\u9069\u306a\u7528\u91cf\u3092\u5bb9\u6613\u304b\u3064\u78ba\u5b9f\u306b\u3001\u6df1\u304f\u9001\u9054\u3067\u304d\u307e\u3059\u3002\u3053\u308c\u306f\u767a\u4f5c\u4e2d\u306b\u60aa\u5fc3\u3084\u5614\u5410\u3092\u7d4c\u9a13\u3059\u308b\u5927\u591a\u6570\u306e\u7247\u982d\u75db\u60a3\u8005\u306b\u3068\u3063\u3066\u3068\u308a\u308f\u3051\u610f\u7fa9\u304c\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002\u3053\u3046\u3057\u305f\u60a3\u8005\u306b\u5bfe\u3057\u3001\u30c8\u30ea\u30d7\u30bf\u30f3\u7cfb\u85ac\u5264\u3001CGRP\u963b\u5bb3\u85ac\u3001\u30b8\u30bf\u30f3\u7cfb\u85ac\u5264\u3001\u305d\u306e\u4ed6\u7247\u982d\u75db\u306e\u6025\u6027\u671f\u6cbb\u7642\u306b\u4f7f\u7528\u3055\u308c\u308b\u975e\u7279\u7570\u7684\u306a\u533b\u85ac\u54c1\u3092\u306f\u3058\u3081\u3068\u3059\u308b\u7d4c\u53e3\u85ac\u3092\u7528\u3044\u308b\u306e\u306b\u306f\u3001\u9650\u754c\u304c\u3042\u308b\u304b\u3089\u3067\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010<\/strong><strong>Impel NeuroPharma<\/strong><strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong><strong><br \/>\n<\/strong>Impel NeuroPharma, Inc\u306f\u30b7\u30a2\u30c8\u30eb\u306b\u672c\u793e\u3092\u7f6e\u304f\u975e\u4e0a\u5834\u306e\u30d0\u30a4\u30aa\u88fd\u85ac\u4f01\u696d\u3067\u3001CNS\u306a\u3069\u9ad8\u3044\u30a2\u30f3\u30e1\u30c3\u30c8\u30e1\u30c7\u30a3\u30ab\u30eb\u30cb\u30fc\u30ba\u306e\u3042\u308b\u75be\u60a3\u3092\u62b1\u3048\u305f\u4eba\u3005\u306e\u305f\u3081\u306e\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u958b\u767a\u306b\u6ce8\u529b\u3057\u3066\u3044\u307e\u3059\u3002\u6025\u6027\u671f\u306e\u7247\u982d\u75db\u6cbb\u7642\u85acTRUDHESA&#x2122;\u3001\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u306e\u30aa\u30d5\u75c7\u72b6\u306b\u5bfe\u3059\u308bINP107\u3001\u7d71\u5408\u5931\u8abf\u75c7\u30841\u578b\u53cc\u6975\u6027\u969c\u5bb3\u3001\u81ea\u9589\u75c7\u306b\u95a2\u9023\u3057\u305f\u6025\u6027\u8208\u596e\u72b6\u614b\u306b\u5bfe\u3059\u308bINP105\u306a\u3069\u3001\u5b9f\u7e3e\u306e\u3042\u308b\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u6709\u52b9\u6027\u3092\u6700\u9069\u5316\u3059\u308b\u3079\u304f\u3001\u5f8c\u671f\u958b\u767a\u6bb5\u968e\u306e\u88fd\u54c1\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u8fc5\u901f\u306b\u62e1\u5145\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010<\/strong><strong>POD\u00ae<\/strong><strong>\uff08<\/strong><strong>Precision Olfactory Delivery<\/strong><strong>\uff09\u6280\u8853\u306b\u3064\u3044\u3066\u3011<\/strong><strong><br \/>\n<\/strong>Impel\u793e\u304c\u72ec\u81ea\u306b\u958b\u767a\u3057\u305f\u30d7\u30ec\u30b7\u30b8\u30e7\u30f3\u30fb\u30aa\u30eb\u30d5\u30a1\u30af\u30c8\u30ea\u30fc\u30fb\u30c7\u30ea\u30d0\u30ea\u30fc\uff08Precision Olfactory Delivery: POD\u00ae\uff09\u30b7\u30b9\u30c6\u30e0\u306f\u3001\u5e45\u5e83\u3044\u6cbb\u7642\u7528\u5206\u5b50\u304a\u3088\u3073\u88fd\u5264\u3092\u3001\u8840\u7ba1\u306e\u5bc6\u96c6\u3057\u305f\u9f3b\u8154\u4e0a\u90e8\u306b\u9001\u9054\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3053\u306e\u7d4c\u8def\u306f\u3001\u3053\u3046\u3057\u305f\u5206\u5b50\u306e\u3053\u308c\u307e\u3067\u6d3b\u7528\u3067\u304d\u306a\u304b\u3063\u305f\u6f5c\u5728\u80fd\u529b\u3092\u6700\u5927\u9650\u5229\u7528\u53ef\u80fd\u306b\u3059\u308b\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u307e\u3059\u3002Impel\u793e\u306e\u9ad8\u7cbe\u5ea6\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u306f\u3001\u4e88\u6e2c\u53ef\u80fd\u306a\u7528\u91cf\u306e\u85ac\u5264\u3092\u9f3b\u8154\u4e0a\u90e8\u306b\u76f4\u63a5\u9001\u9054\u3059\u308b\u3053\u3068\u3067\u3001\u85ac\u5264\u306e\u5438\u53ce\u3092\u5897\u5927\u3001\u5b89\u5b9a\u3055\u305b\u308b\u305f\u3081\u306b\u8a2d\u8a08\u3055\u308c\u3001\u4ed6\u306e\u7d4c\u9f3b\u9001\u9054\u30b7\u30b9\u30c6\u30e0\u306b\u968f\u4f34\u3059\u308b\u9ad8\u3044\u53ef\u5909\u6027\u3092\u6291\u3048\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u6295\u4e0e\u90e8\u4f4d\u3068\u3057\u3066\u306f\u7406\u60f3\u7684\u3067\u3042\u308a\u306a\u304c\u3089\u3001\u9f3b\u8154\u4e0a\u90e8\u3078\u85ac\u7269\u9001\u9054\u3067\u304d\u308b\u30b7\u30b9\u30c6\u30e0\u306f\u4ed6\u306b\u307e\u3060\u958b\u767a\u3055\u308c\u3066\u3044\u307e\u305b\u3093\u3002Impel\u793e\u306f\u3001\u3053\u306e\u6295\u4e0e\u7d4c\u8def\u3092\u5229\u7528\u3059\u308b\u3053\u3068\u3067\u8a66\u9a13\u7684\u6cbb\u7642\u306e\u8840\u4e2d\u6fc3\u5ea6\u304c\u7b4b\u8089\u5185\uff08IM\uff09\u6295\u4e0e\u3068\u540c\u7b49\u306e\u30ec\u30d9\u30eb\u3067\u3042\u308a\u3001\u9759\u8108\u5185\uff08IV\uff09\u6295\u4e0e\u306e\u3088\u3046\u306a\u5168\u8eab\u6027\u6295\u4e0e\u306e\u30ec\u30d9\u30eb\u306b\u8fc5\u901f\u306b\u5230\u9054\u53ef\u80fd\u3067\u3042\u308b\u3053\u3068\u3092\u5b9f\u8a3c\u3057\u3066\u304a\u308a\u3001\u591a\u304f\u306e\u75be\u60a3\u306e\u6cbb\u7642\u72b6\u6cc1\u3092\u4e00\u5909\u3055\u305b\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u91cd\u8981\u306a\u70b9\u3068\u3057\u3066\u306f\u3001POD\u6280\u8853\u306f\u30c9\u30e9\u30a4\u30d1\u30a6\u30c0\u30fc\u304a\u3088\u3073\u6db2\u4f53\u88fd\u5264\u306e\u5674\u9727\u5264\u306b\u3088\u308b\u9001\u9054\u304c\u53ef\u80fd\u3067\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u547c\u5438\u306e\u30bf\u30a4\u30df\u30f3\u30b0\u3092\u8abf\u6574\u3059\u308b\u5fc5\u8981\u304c\u306a\u304f\u306a\u308a\u3001\u81ea\u5df1\u6295\u4e0e\u3042\u308b\u3044\u306f\u4ecb\u8b77\u8005\u306b\u3088\u308b\u6295\u4e0e\u304c\u3067\u304d\u3001\u60a3\u8005\u306e\u30a2\u30a6\u30c8\u30ab\u30e0\u3068\u5feb\u9069\u3055\u3092\u5411\u4e0a\u3055\u305b\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u5411\u4e0a\u3082\u898b\u8fbc\u3081\u307e\u3059\u3002<\/p>\n<p>IMPEL\u3001POD\u304a\u3088\u3073IMPE\u306e\u30ed\u30b4\u306fImpel NeuroPharma, Inc\u306e\u767b\u9332\u5546\u6a19\u3067\u3059\u3002Impel NeuroPharma\u793e\u306e\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001<a href=\"http:\/\/impelnp.com\">http:\/\/impelnp.com<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010<\/strong><strong>Veeva Systems<\/strong><strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong><br \/>\nVeeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u3001950\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n\u8a73\u3057\u304f\u306f\u3001<a href=\"https:\/\/veeva.com\/jp\/\">https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>\u3010Forward-looking Statements\u3011<\/p>\n<p>This release contains forward-looking statements, including the statements regarding the expected impact and benefits of Veeva\u2019s conversion to a Delaware public benefit corporation. Any forward-looking statements contained in this press release are based upon Veeva\u2019s current expectations, historical performance and its current plans and estimates, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including potentially negative reactions to our conversion to a Delaware public benefit corporation. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended October 31, 2020. This is available on the company\u2019s website at <a href=\"http:\/\/veeva.com\/\">veeva.com<\/a>\u00a0under the Investors section and on the SEC\u2019s website at\u00a0<a href=\"http:\/\/sec.gov\/\">sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Impel\u793e\u306fVeeva Commercial Cloud\u306e\u5c0e\u5165\u3067\u3001\u30c7\u30fc\u30bf\u3001\u30bd\u30d5\u30c8\u30a6\u30a8\u30a2\u3001\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u30b5\u30fc\u30d3\u30b9\u3092\u7db2\u7f85\u3059\u308b\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30b9\u30a4\u30fc\u30c8\u306e\u3059\u3079\u3066\u3092\u5229\u7528\u3057\u3001\u6226\u7565\u7684\u306b\u73fe\u5834\u306e\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u52a0\u901f\u3067\u304d\u308b\u3088\u3046\u306b\u3002<\/p>\n","protected":false},"author":131,"featured_media":44859,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-44858","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/44858"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=44858"}],"version-history":[{"count":1,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/44858\/revisions"}],"predecessor-version":[{"id":44864,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/44858\/revisions\/44864"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media\/44859"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=44858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=44858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=44858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}